Seed Co

Seed Co Receivables

The Accounts Receivable of Seed Co (7743.T) as of Oct 29, 2026 is 4.60 B JPY. In the previous year, Accounts Receivable was 4.40 B JPY — a change of 4.47% (higher).

Receivables

4.60 BJPY

YoY

4.47%

Last updated:

Accounts Receivable of Seed Co is 2025 4.60 B JPY. Accounts Receivable of Seed Co was 2024 4.40 B JPY. It decreases by 4.47% higher compared to the previous year.

The Seed Co Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2018
4.27 B JPY
Jan 1, 2019
4.64 B JPY
Jan 1, 2020
4.95 B JPY
Jan 1, 2021
4.34 B JPY
Jan 1, 2022
4.35 B JPY
Jan 1, 2023
4.26 B JPY
Jan 1, 2024
4.40 B JPY
Jan 1, 2025
4.60 B JPY
The Seed Co Receivables history
YEARReceivablesYoY
4.60 BJPY+4.47%
4.40 BJPY+3.32%
4.26 BJPY-2.10%
4.35 BJPY+0.31%
4.34 BJPY-12.26%
4.95 BJPY+6.52%
4.64 BJPY+8.75%
4.27 BJPY+14.10%
3.74 BJPY+4.30%
3.59 BJPY+9.55%
3.28 BJPY-15.06%
3.86 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Seed Co Stock analysis

What does Seed Co do? Seed Co., Ltd. generates revenue through its Contact Lens and Care Products segment, which offers hard, soft, and disposable contact lenses alongside lens care solutions including preservation, cleansing, enzyme cleaning, disinfectant solutions, and lens cases. The Glasses segment contributes by selling eyeglass frames and fixtures. The company also engages in intraocular lens production as part of its broader business. Revenue streams are derived from direct sales of these products to consumers and healthcare providers within the eye care market. The Contact Lens and Care Products segment targets consumers seeking daily or extended-wear contact lenses and related maintenance products. The Glasses segment serves customers purchasing eyewear frames and accessories. Intraocular lenses are likely sold to medical professionals for surgical procedures. Product categories include disposable lenses, care solutions, frames, and surgical lenses, each appealing to distinct market segments. Seed Co., Ltd. focuses on manufacturing and selling contact lenses, lens care, eyeglasses, and intraocular lenses. Its primary revenue comes from contact lens sales, particularly disposable options, and care product bundles. The Glasses segment provides complementary revenue through frame and fixture sales. Intraocular lenses represent a specialized revenue stream within the medical device sector, targeting ophthalmic surgeons and clinics. Seed Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Seed Co stock

Accounts Receivable of Seed Co is 4.60 B JPY in 2025.

Accounts Receivable of Seed Co changed from 4.40 B JPY to 4.60 B JPY, representing a 4.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Seed Co since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Seed Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Seed Co

All Key Metrics — Seed Co